Human CRISPR Inhibition 10x Compatible Druggable Library

pkg of 5 vials (5x200µL aliquots )

≥5x108 VP/ml (via p24 Assay)

CRISPR

dry ice

−70℃

The 10x Compatible Human CRISPRi Kinase Phosphatase Drug Targets Kit (Druggable Genome) contains one sub-pool of the top two ranked sgRNAs per gene for increased sensitivity and includes non-targeting controls built-in. In addition, the LV15 vector has both BFP and puromycin as selection markers and an optimized scaffold with capture sequence 2 (CS2, Compatible with 10x Feature Barcode technology) for sgRNA expression and function.

Custom pools for follow-up screening or 10x Genomics Compatible CRISPR pools are also available by contacting your local sales representative.

The power of CRISPR for genome engineering, coupled with the ability to perform large-scale, whole-genome loss-of-function (LOF) screening, has allowed breakthroughs in identifying gene pathways in drug resistance and disease. CRISPR is most commonly used to create double-stranded breaks that often result in loss of gene function (CRISPR-KO). However, the full extent of CRISPR′s utility extends beyond just targeted cutting of DNA. CRISPR′s Nuclease-independent applications provide equal targeting specificity. Instead of cutting, CRISPRi allows for targeted interference of gene function by delivering transcriptional repressor domains to a specific target sequence using modified dCas9 + gRNA complexes. Gene knockdown complements CRISPR-KO and CRISPRa (activation) and has distinct advantages over existing loss-of-function strategies like RNAi. As a world leader in producing lentiviral libraries, we design and build custom pools to any specifications. With this capability, we have partnered with 10x Genomics to bring innovative pooled screening products to enable discovery at single-cell resolution

10 - Combustible liquids

WGK 1